(INH) Indus Holding - Ratings and Ratios
Manufacturing, Technology, Logistics, Automation, Medical
INH EPS (Earnings per Share)
INH Revenue
Description: INH Indus Holding
INDUS Holding AG is a private equity firm with a focused investment strategy, targeting mid-market companies in specific industries such as energy and environmental technology, automation, and medical engineering. The firms investment approach is characterized by a preference for long-term holdings in companies with strong financials, including an equity rate above 30% and double-digit EBIT margins.
The companys investment scope is limited to small and medium-sized businesses based in Germany, Switzerland, Austria, and other German-speaking European regions, with annual sales between €20 million and €100 million. INDUS Holding AG typically seeks to acquire majority stakes in its portfolio companies, with the goal of eventually holding 100% ownership. The firm prioritizes owner-managed companies with low or no bank liabilities.
With a foundation established in 1989, INDUS Holding AG has a proven track record in mergers and acquisitions, corporate spin-offs, and long-term investment strategies. The companys investment activities are funded through its balance sheet, allowing for a flexible and opportunistic approach to identifying and capitalizing on attractive investment opportunities.
Analyzing the provided technical data, we observe that the stocks current price is €22.85, with a 20-day SMA of €21.42 and a 50-day SMA of €21.93, indicating a positive short-term trend. The 200-day SMA at €21.07 further supports a bullish outlook. With an ATR of 0.54, representing a 2.38% daily volatility, the stock exhibits moderate price fluctuations.
From a fundamental perspective, INDUS Holding AGs market capitalization stands at €517.83 million, with a P/E ratio of 8.97 and a forward P/E of 7.40, suggesting a relatively undervalued position. The companys RoE of 8.47% indicates a decent return on equity. Considering these factors, a forecast for the stock could be derived by analyzing the interplay between its technical and fundamental data.
Based on the provided data, a potential forecast could involve a price target derived from the stocks historical volatility and its current trend. If the stock continues its upward trajectory, it may reach the upper end of its 52-week range, potentially approaching €26.80. Conversely, a decline could see the stock testing its 52-week low of €18.58. Given the current technical and fundamental indicators, a moderate growth trajectory is plausible, with potential for the stock to reach €25.00 in the short to medium term, contingent upon maintaining its current trend and fundamental stability.
INH Stock Overview
Market Cap in USD | 668m |
Sub-Industry | Industrial Conglomerates |
IPO / Inception |
INH Stock Ratings
Growth Rating | 4.52 |
Fundamental | 54.1% |
Dividend Rating | 50.5 |
Rel. Strength | -7.71 |
Analysts | - |
Fair Price Momentum | 23.49 EUR |
Fair Price DCF | 23.09 EUR |
INH Dividends
Dividend Yield 12m | 5.53% |
Yield on Cost 5y | 5.05% |
Annual Growth 5y | -5.59% |
Payout Consistency | 93.7% |
Payout Ratio | 80.2% |
INH Growth Ratios
Growth Correlation 3m | 73.1% |
Growth Correlation 12m | 59.4% |
Growth Correlation 5y | -52.3% |
CAGR 5y | -1.09% |
CAGR/Max DD 5y | -0.02 |
Sharpe Ratio 12m | -0.13 |
Alpha | -5.90 |
Beta | 0.787 |
Volatility | 33.58% |
Current Volume | 39.1k |
Average Volume 20d | 24.7k |
Stop Loss | 21.7 (-3.6%) |
Signal | -1.11 |
Piotroski VR‑10 (Strict, 0-10) 6.5
Net Income (59.4m TTM) > 0 and > 6% of Revenue (6% = 102.8m TTM) |
FCFTA 0.03 (>2.0%) and ΔFCFTA -5.55pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 18.37% (prev 23.39%; Δ -5.02pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.06 (>3.0%) and CFO 115.4m > Net Income 59.4m (YES >=105%, WARN >=100%) |
Net Debt (590.6m) to EBITDA (217.3m) ratio: 2.72 <= 3.0 (WARN <= 3.5) |
Current Ratio 1.65 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (24.9m) change vs 12m ago -6.48% (target <= -2.0% for YES) |
Gross Margin 46.92% (prev 46.41%; Δ 0.51pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 91.69% (prev 92.45%; Δ -0.76pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 4.48 (EBITDA TTM 217.3m / Interest Expense TTM 26.1m) >= 6 (WARN >= 3) |
Altman Z'' 2.54
(A) 0.17 = (Total Current Assets 797.5m - Total Current Liabilities 482.6m) / Total Assets 1.84b |
(B) 0.19 = Retained Earnings (Balance) 342.3m / Total Assets 1.84b |
(C) 0.06 = EBIT TTM 116.7m / Avg Total Assets 1.87b |
(D) 0.37 = Book Value of Equity 412.2m / Total Liabilities 1.12b |
Total Rating: 2.54 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 54.11
1. Piotroski 6.50pt = 1.50 |
2. FCF Yield 5.59% = 2.79 |
3. FCF Margin 3.57% = 0.89 |
4. Debt/Equity 0.90 = 2.11 |
5. Debt/Ebitda 2.94 = -1.68 |
6. ROIC - WACC 0.60% = 0.75 |
7. RoE 8.47% = 0.71 |
8. Rev. Trend -40.91% = -2.05 |
9. Rev. CAGR -7.00% = -1.17 |
10. EPS Trend data missing |
11. EPS CAGR 2.48% = 0.25 |
What is the price of INH shares?
Over the past week, the price has changed by -5.26%, over one month by -3.02%, over three months by +9.00% and over the past year by +10.78%.
Is Indus Holding a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of INH is around 23.49 EUR . This means that INH is currently overvalued and has a potential downside of 4.4%.
Is INH a buy, sell or hold?
What are the forecasts/targets for the INH price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 31.7 | 40.9% |
Analysts Target Price | - | - |
ValueRay Target Price | 25.2 | 12.2% |
INH Fundamental Data Overview
Market Cap EUR = 570.1m (570.1m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 114.9m EUR (last quarter)
P/E Trailing = 9.8707
P/E Forward = 8.244
P/S = 0.3318
P/B = 0.8338
P/EG = 1.67
Beta = 1.393
Revenue TTM = 1.71b EUR
EBIT TTM = 116.7m EUR
EBITDA TTM = 217.3m EUR
Long Term Debt = 471.7m EUR (from longTermDebt, last quarter)
Short Term Debt = 167.5m EUR (from shortTermDebt, last quarter)
Debt = 639.2m EUR (Calculated: Short Term 167.5m + Long Term 471.7m)
Net Debt = 590.6m EUR (from netDebt column, last quarter)
Enterprise Value = 1.09b EUR (570.1m + Debt 639.2m - CCE 114.9m)
Interest Coverage Ratio = 4.48 (Ebit TTM 116.7m / Interest Expense TTM 26.1m)
FCF Yield = 5.59% (FCF TTM 61.2m / Enterprise Value 1.09b)
FCF Margin = 3.57% (FCF TTM 61.2m / Revenue TTM 1.71b)
Net Margin = 3.46% (Net Income TTM 59.4m / Revenue TTM 1.71b)
Gross Margin = 46.92% ((Revenue TTM 1.71b - Cost of Revenue TTM 909.8m) / Revenue TTM)
Tobins Q-Ratio = 2.65 (Enterprise Value 1.09b / Book Value Of Equity 412.2m)
Interest Expense / Debt = 0.85% (Interest Expense 5.41m / Debt 639.2m)
Taxrate = 43.07% (from yearly Income Tax Expense: 41.4m / 96.1m)
NOPAT = 66.5m (EBIT 116.7m * (1 - 43.07%))
Current Ratio = 1.65 (Total Current Assets 797.5m / Total Current Liabilities 482.6m)
Debt / Equity = 0.90 (Debt 639.2m / last Quarter total Stockholder Equity 709.1m)
Debt / EBITDA = 2.94 (Net Debt 590.6m / EBITDA 217.3m)
Debt / FCF = 10.45 (Debt 639.2m / FCF TTM 61.2m)
Total Stockholder Equity = 701.2m (last 4 quarters mean)
RoA = 3.23% (Net Income 59.4m, Total Assets 1.84b )
RoE = 8.47% (Net Income TTM 59.4m / Total Stockholder Equity 701.2m)
RoCE = 9.95% (Ebit 116.7m / (Equity 701.2m + L.T.Debt 471.7m))
RoIC = 5.06% (NOPAT 66.5m / Invested Capital 1.31b)
WACC = 4.46% (E(570.1m)/V(1.21b) * Re(8.92%)) + (D(639.2m)/V(1.21b) * Rd(0.85%) * (1-Tc(0.43)))
Shares Correlation 5-Years: -97.50 | Cagr: -1.52%
Discount Rate = 8.92% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 67.28% ; FCFE base≈104.3m ; Y1≈70.4m ; Y5≈34.1m
Fair Price DCF = 23.09 (DCF Value 574.9m / Shares Outstanding 24.9m; 5y FCF grow -37.93% → 3.0% )
Revenue Correlation: -40.91 | Revenue CAGR: -7.00%
Revenue Growth Correlation: 8.43%
EPS Correlation: N/A | EPS CAGR: 2.48%
EPS Growth Correlation: 32.14%